Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Megan Kruse"'
Publikováno v:
Case Reports in Oncological Medicine, Vol 2019 (2019)
Synchronous tumors are defined as two tumors arising concurrently or within six months of each other. Reports of synchronous RCC and breast cancer are limited to nonmetastatic renal cell carcinoma (RCC) and hormone receptor-positive infiltrative duct
Externí odkaz:
https://doaj.org/article/50daedcc6cd947f782b319a486223223
Publikováno v:
The American Journal of Surgery. 225:549-552
The oncologic outcomes of patients diagnosed with inflammatory breast cancer (IBC) based on clinical exam only versus those with dermal lymphatic invasion on skin punch biopsy may be different and are worth further investigation.Patients diagnosed fr
Autor:
Kevin M Kalinsky, Megan Kruse, Emily Nash Smyth, Claudia M Guimaraes, Santosh Gautam, Alnecia R Nisbett, Maxine D Fisher, Zhanglin Lin Cui, Lee Bowman
Publikováno v:
Cancer Research. 82:P1-18
Background: Cyclin-dependent kinase 4 and 6 inhibitors (CDK4 & 6i) provide significant benefit for patients (pts) with HR+, HER2- MBC, however, clinical questions remain regarding the optimal sequence (seq) of treatments (tx). Prior analyses of real
Publikováno v:
Cancer Research. 82:P1-24
Introduction:Inflammatory breast cancer (IBC) is a rare and aggressive malignancy with a 5-year relapse free survival (RFS) previously reported to be approximately 40%. Standard treatment is tri-modality therapy consisting of neoadjuvant chemotherapy
Autor:
George Thomas Budd, Justin M. Johnson, Emily Rhoades, Halle Moore, Holly Levengood, Megan Kruse, Erin Roesch, Jame Abraham, Brenna Elliott, Elena Haury, Rachel Swartz, Holly Pederson, Zahraa Al Hilli, Vincent Tuohy
Publikováno v:
Cancer Research. 83:3035-3035
Background: Triple-negative breast cancer (TNBC) has a poor prognosis and may be associated with germline mutations. α-lactalbumin (aLA) is expressed in lactating breasts but not at other times or in other tissues. Expression of aLA is found in 70%
Autor:
Chirag Shah, Pat Whitworth, Stephanie Valente, Graham S. Schwarz, Megan Kruse, Manpreet Kohli, Kirstyn Brownson, Laura Lawson, Beth Dupree, Frank A. Vicini
Publikováno v:
Breast cancer research and treatment.
Purpose Breast cancer-related lymphedema (BCRL) represents a significant concern for patients following breast cancer treatment, and assessment for BCRL represents a key component of survivorship efforts. Growing data has demonstrated the benefits of
Autor:
Sebastian Contreras Cubillos, Roberto Rodríguez-Labrada, Matthis Synofzik, Tamara Canento, Winfried Ilg, Jacqueline Medrano-Montero, Yaimeé Vázquez-Mojena, Sandra Rojas, Luis Velázquez-Pérez, Melissa P. Cyngler, Fernanda Maldonado, Reidenis Torres-Vega, Megan Kruse, Michelle Magee, Adam P. Vogel
Publikováno v:
Neurology 95(2), e194-e205 (2020). doi:10.1212/WNL.0000000000009776
ObjectiveTo determine whether objective and quantitative assessment of dysarthria and dysphagia in spinocerebellar ataxia type 2 (SCA2), specifically at pre-ataxic and early disease phases, can act as sensitive disease markers.MethodsForty-six indivi
Autor:
Steffi Oesterreich, Azadeh Nasrazadani, Jian Zou, Neil Carleton, Tiffany Onger, Matthew D Wright, Yujia Li, Kathryn Demanelis, Bhuvaneswari Ramaswamy, George Tseng, Adrian V Lee, Nicole Williams, Megan Kruse
Publikováno v:
Journal of the National Cancer Institute. 114(11)
Background There is increasing interest in better understanding the biology and clinical presentation of invasive lobular cancer (ILC), which is the most common special histological subtype of breast cancer. Limited large contemporary data sets are a
Autor:
Megan Kruse, Thomas U. Marron, Elizabeth M. Gaughan, Mateusz Opyrchal, Aileen Ryan, Kristen Aufiero, Craig L. Slingluff, Nicole Edmonds, Brian R. Gastman, Philip Friedlander, Igor Puzanov, Ralph Venhaus, Mary J. Macri, Paul Schwarzenberger, Patrick M. Dillon, Ileana S. Mauldin, Mansi Saxena, Toni Ricciardi, Nina Bhardwaj
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A363-A363
BackgroundIntratumoral (IT) cancer therapies may enhance T cell activation and tumor infiltration when combined with systemic checkpoint blockade. This approach may improve treatment of advanced breast cancer, which is commonly resistant to immune th
Autor:
Jame Abraham, Anjali Advani, Per Basse, Shailender Bhatia, Patrick M. Boland, Hongbin Chen, Grace K. Dy, Marc S. Ernstoff, Christos Fountzilas, Gregory K. Friedman, G. Yancey Gillespie, Ahmad Hanif, Michael R. Harrison, Brant A. Inman, Fumito Ito, Renuka V. Iyer, Pawel Kalinski, Sumera Khan, Megan Kruse, Sunyoung S. Lee, Sylvia Lee, Matthew Loecher, Ali A. Maawy, Paul Mayor, Megan A. McNamara, Igor Puzanov, Eric K. Ring, Yazeed Sawalha, Kristen Starbuck, Tian Zhang, Emese Zsiros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a55536c92ed9a150b17bf6e425e4d5c
https://doi.org/10.1016/b978-0-323-54948-6.01002-7
https://doi.org/10.1016/b978-0-323-54948-6.01002-7